Exclusion criteria included patients younger than 18 years, any patient with a death date on or before the index date (deceased patients at baseline), individuals with pre-existing conditions known to impact gastrointestinal GI functions, e.g., major GI or abdominal surgeries, connective tissue disorders (e.g., amyloidosis, Ehlers-Danlos syndrome, Sjgrens syndrome), inflammatory bowel diseases, and other major systemic or GI conditions (cystic fibrosis, intestinal failure, etc.) predisposing to SIBO
Stacking them is physiologically redundant in part: tesamorelin raises endogenous GH and downstream IGF-1, while IGF-1 LR3 adds direct IGF-1R stimulation on top
Experimental studies suggest it reduces inflammation in injured tissues, promoting faster recovery
For maximum benefits, apply regularly to the scalp
Heres where keto comes in